Panel rejects strong epilepsy drug warning
BELTSVILLE, Maryland (Reuters) - Anti-seizure drugs for treating epilepsy carry an increased risk of suicidal thoughts and behavior, but not enough to warrant a black box warning, a U.S. advisory panel concluded on Thursday.
<p><img src="http://feeds.feedburner.com/~a/reuters/healthNews?i=IszRmX" border="0"></img> (http://feeds.feedburner.com/~a/reuters/healthNews?a=IszRmX)</p><div class="feedflare">
<img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=ssoJrJ" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=ssoJrJ) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=onHGhj" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=onHGhj) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=vNGidj" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=vNGidj)
</div><img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/332106680" height="1" width="1"/>
http://feeds.feedburner.com/~r/reuters/healthNews/~3/332106680/idUSN1048371720080710